Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology

J Diabetes. 2013 Dec;5(4):406-15. doi: 10.1111/1753-0407.12056. Epub 2013 Jun 4.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries, affecting 20%-33% of the general population. Large population-based surveys in China indicate a prevalence of approximately 15%-30%. Worldwide, including in China, the prevalence of NAFLD has increased rapidly in parallel with regional trends of obesity, type 2 diabetes and metabolic syndrome. In addition, NAFLD has contributed significantly to increased overall, as well as cardiovascular and liver-related, mortality in the general population. In view of rapid advances in research into NAFLD in recent years, this consensus statement provides a brief update on the progress in the field and suggests preferred approaches for the comprehensive management of NAFLD and its related metabolic diseases.

Keywords: NAFLD; diagnosis; management; metabolic disorders; 非酒精性脂肪性肝病,代谢紊乱,诊断,处理.

Publication types

  • Review

MeSH terms

  • China
  • Consensus*
  • Endocrinology / standards*
  • Fatty Liver / complications
  • Fatty Liver / diagnosis*
  • Fatty Liver / therapy*
  • Humans
  • Liver / metabolism
  • Metabolic Diseases / diagnosis
  • Metabolic Diseases / etiology*
  • Metabolic Diseases / therapy
  • Non-alcoholic Fatty Liver Disease
  • Practice Guidelines as Topic*
  • Societies, Medical / standards